Related Experiment Videos
Making protein interactions druggable: targeting PDZ domains.
1Neuroscience Research, Novartis Institutes for BioMedical Research, Novartis Pharma AG, WSJ-386.7.43, CH-4002 Basel, Switzerland. kumlesh_k.dev@pharma.novartis.com
Nature Reviews. Drug Discovery
|December 2, 2004
Summary
Targeting protein-protein interactions with drugs is challenging. PDZ domains offer potential drug targets due to their defined binding sites, but further research is needed to understand their function for therapeutic development.
Area of Science:
- Biochemistry
- Molecular Biology
- Drug Discovery
Background:
- Protein-protein interactions (PPIs) are crucial in disease pathways.
- Modulating PPIs is a promising therapeutic strategy.
- PDZ domains mediate numerous PPIs across cellular contexts.
Purpose of the Study:
- To highlight the potential of PDZ domains as drug targets.
- To emphasize the challenges in developing drugs that modulate PDZ interactions.
Main Methods:
- Review of PDZ domain structure and function.
- Analysis of PDZ domains in disease-related pathways.
- Exploration of drug discovery approaches targeting PDZ domains.
Main Results:
- PDZ domains possess well-defined binding sites, making them attractive for drug design.
- Understanding the diverse functions of PDZ domains is critical for successful drug development.
Conclusions:
- PDZ domains represent promising targets for therapeutic intervention.
- Further research into PDZ domain function is essential for realizing their drug development potential.